Compound Summary
Compound Information
pyrazinamide
Compound Name: | pyrazinamide |
Compound CID: | 1046 |
Synonyms: | pyrazinamide pyrazinecarboxamide 98-96-4 pyrazine-2-carboxamide pyrazinoic acid amide More... |
Iupac Name: | pyrazine-2-carboxamide |
InChI: | InChI=1S/C5H5N3O/c6-5(9)4-3-7-1-2-8-4/h1-3H,(H2,6,9) |
InChIKey: | IPEHBUMCGVEMRF-UHFFFAOYSA-N |
Canonical Smiles: | C1=CN=C(C=N1)C(=O)N |
Isomeric Smiles: | C1=CN=C(C=N1)C(=O)N |
Molecular Weight: | 123.11 |
Molecular Formula: | C5H5N3O |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
pyrazinamide
Molecular Weight: | 123.11 |
Molecular Formula: | C5H5N3O |
Hydrogen Bond Donor Count: | 1 |
Hydrogen Bond Acceptor Count: | 3 |
Rotatable Bond Count: | 1 |
Heavy Atom Count: | 9 |
Complexity: | 115 |
Synonyms
pyrazinamide
| pyrazinamide | pyrazinamide |
|---|---|
pyrazinamide |
pyrazinecarboxamide |
98-96-4 |
pyrazine-2-carboxamide |
pyrazinoic acid amide |
2-Pyrazinecarboxamide |
Zinamide |
Aldinamide |
Tebrazid |
Aldinamid |
Pirazinamid |
Pyrazineamide |
Pyrafat |
Unipyranamide |
Farmizina |
Pirazimida |
pyrazine carboxylamide |
Eprazin |
Novamid |
2-Carbamylpyrazine |
Pyrazinecarboxylic acid amide |
Pyrazinamidum |
Pirazinamide |
Pyrazine carboxamide |
D-50 |
MK 56 |
C5H5N3O |
PZA |
NCI-C01785 |
UNII-2KNI5N06TI |
MFCD00006132 |
NSC 14911 |
T 165 |
Pirazinamida |
Tisamid |
Isopas |
2KNI5N06TI |
MLS000069730 |
Pezetamid |
Piraldina |
CHEBI:45285 |
NSC14911 |
Pyrazinamide (Pyrazinoic acid amide) |
NSC-14911 |
NCGC00015833-09 |
Pyrazinamdie |
SMR000036662 |
Pirazinamide DCIT |
DSSTox_CID_1215 |
DSSTox_RID_76014 |
DSSTox_GSID_21215 |
Pyrazinamidum INN-Latin |
Pirazinamida INN-Spanish |
Rifafour |
D-50 (VAN) |
DRG 0124 |
CAS-98-96-4 |
CCRIS 545 |
Pyrazinamide (TN) |
Rifafour e-200 |
HSDB 3576 |
SR-01000076077 |
EINECS 202-717-6 |
BRN 0112306 |
pyrazinamida |
Pyrizinamide |
pyrazine amide |
AZT + Pyrazinamide combination |
Pyrazine-2-carboxylic acid amide |
Pyrazinamide,(S) |
Pyrazinamide USP:INN:BAN:JAN |
Prestwick_811 |
ACMC-20aive |
2-pyrazine carboxamide |
Spectrum_000902 |
Opera_ID_735 |
Prestwick0_000514 |
Prestwick1_000514 |
Prestwick2_000514 |
Prestwick3_000514 |
Spectrum2_001305 |
Spectrum3_001046 |
Spectrum4_001186 |
Spectrum5_001026 |
Lopac-P-7136 |
CHEMBL614 |
P 7136 |
WLN: T6N DNJ BVZ |
pyrazine-2-carboximidic acid |
Lopac0_001011 |
SCHEMBL24102 |
BSPBio_000467 |
BSPBio_002572 |
KBioGR_001851 |
KBioSS_001382 |
5-25-04-00178 (Beilstein Handbook Reference) |
MLS002222347 |
BIDD:GT0228 |
DivK1c_000241 |
SPECTRUM1500518 |
SPBio_001369 |
SPBio_002388 |
BPBio1_000515 |
EBD430 |
GTPL7287 |
ZINC2005 |
DTXSID9021215 |
2-pyrazinecarboxylic acid amide; |
HMS500M03 |
KBio1_000241 |
KBio2_001382 |
KBio2_003950 |
KBio2_006518 |
KBio3_001792 |
Pyrazinamide (JP17/USP/INN) |
NINDS_000241 |
BDBM228814 |
HMS1569H09 |
HMS1920N08 |
HMS2092E09 |
HMS2096H09 |
HMS2235G17 |
HMS3259O04 |
HMS3263K03 |
HMS3371G09 |
HMS3655A10 |
HMS3713H09 |
KUC109577N |
Pharmakon1600-01500518 |
ACT01761 |
AMY14180 |
BCP30257 |
HY-B0271 |
KSC-27-052E |
Pyrazine-d3-carboxamide-15N |
Tox21_110237 |
Tox21_202059 |
Tox21_302771 |
Tox21_501011 |
BBL010592 |
CCG-39243 |
NSC757304 |
s1762 |
SBB004276 |
STK801661 |
AKOS000120280 |
Tox21_110237_1 |
DB00339 |
LP01011 |
MCULE-6846697749 |
NC00534 |
NSC-757304 |
Pyrazinecarboxamide, analytical standard |
SDCCGSBI-0050984.P005 |
IDI1_000241 |
NCGC00015833-01 |
NCGC00015833-02 |
NCGC00015833-03 |
NCGC00015833-04 |
NCGC00015833-05 |
NCGC00015833-06 |
NCGC00015833-07 |
NCGC00015833-08 |
NCGC00015833-10 |
NCGC00015833-11 |
NCGC00015833-12 |
NCGC00015833-15 |
NCGC00015833-16 |
NCGC00015833-25 |
NCGC00090695-01 |
NCGC00090695-03 |
NCGC00090695-04 |
NCGC00090695-05 |
NCGC00090695-06 |
NCGC00090695-07 |
NCGC00256336-01 |
NCGC00259608-01 |
NCGC00261696-01 |
Pyrazinoic acid amide; pyrazinamide; PZA |
CAS- 98-96-4 |
SY013550 |
TS-01626 |
SBI-0050984.P004 |
AB0008224 |
DB-002866 |
AB00052083 |
B2122 |
BB 0253141 |
EU-0101011 |
FT-0659757 |
P0633 |
ST45022155 |
SW196945-3 |
C01956 |
D00144 |
D70481 |
J10111 |
1,2-dihydro-1,2,4-triazol-3-one;Pyrazinamide |
AB00052083-16 |
AB00052083_17 |
AB00052083_18 |
A845937 |
AC-907/25014068 |
Q417571 |
SR-01000076077-1 |
SR-01000076077-4 |
SR-01000076077-6 |
W-100059 |
Z33546644 |
Pyrazinamide, British Pharmacopoeia (BP) Reference Standard |
Pyrazinamide, European Pharmacopoeia (EP) Reference Standard |
2-Carbamylpyrazine ;Aldinamid ;Aldinamide; Pyrazinoic acid amide |
Pyrazinamide, United States Pharmacopeia (USP) Reference Standard |
Pyrazinamide, Pharmaceutical Secondary Standard; Certified Reference Material |
Experimental Data
pyrazinamide
| Species | Dosage | Unit | CG Lifespan(AVG/MED days) | TG Lifespan(AVG/MED days) | Lifespan Change(AVG/MED%) | CG Lifespan(MAX days) | TG Lifespan(MAX days) | Lifespan Change(MAX%) | Significant | Strain | Gender | PubMed | Active Label |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33 | umol/L | -2 | NS | N2 | 24134630 | Inactive |
Experimental Data Visualization
pyrazinamide
Statistics Data
pyrazinamide
| Species | Lifespan Change(AVG/MED%) | Lifespan Change(MAX%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | -2 | 1 | 1 |
Statistics Data Visualization
pyrazinamide
